Simple Summary Gastric cancer is a deadly disease with worldwide prevalence that is often
diagnosed at late stages. About two-thirds of patients in Western countries will present with …

Gastric adenocarcinoma (GAC) is one of the most aggressive malignancies and has a
dismal prognosis. Therefore, multimodality therapies to include surgery, chemotherapy …

Objective: We compare neoadjuvant chemotherapy (CT) to neoadjuvant chemotherapy plus
chemoradiation (CRT) for patients with gastric adenocarcinoma (GA). Summary of …

Abstract Background and Objectives We sought to evaluate the impact of lymphovascular
invasion (LVI) and perineural invasion (PNI) on survival outcomes in gastric cancer patients …

Background The goal of surveillance testing is to enable curative salvage therapy through
early disease detection, however supporting evidence in gastroesophageal …

Gastric cancer is highly prevalent in China, yet early diagnosis and overall survival rates are
low. The primary treatment strategy is comprehensive therapy centered on surgery. Studies …

Background We compared oncologic outcomes of patients who received neoadjuvant
chemotherapy (CT) with those of patients who received neoadjuvant chemotherapy plus …

Objective: We aimed to evaluate the frequency of paratracheal lymph nodes (LN)
metastases and their prognostic influence. Summary Background Data: Paratracheal LNs …

Purpose Despite improvements in multimodal treatment of locally advanced
esophagogastric adenocarcinoma, the majority of patients still relapses. The impact of …

Gastric adenocarcinoma (GAC) is estimated as the fifteenth most common cancer in the
USA. Incidence rate has been gradually decreasing, but prognosis remains dismal. For …